BIODRUGS

打开微信扫一扫

期刊ISSN

1173-8804

E-ISSN

1179-190X

影响因子

登录后查看数据

自引率

2.9%

SCI期刊JCR分区

SCI期刊JCR分区等级：1区

按学科分区
IMMUNOLOGY Q1
ONCOLOGY Q1
PHARMACOLOGY & PHARMACY Q1
IMMUNOLOGY Q1
ONCOLOGY Q1
PHARMACOLOGY & PHARMACY Q1

《新锐期刊分区表》

（2026年3月发布）

大类学科	小类学科	Top期刊	综述期刊
医学 2区	肿瘤学 2区	否	否
	免疫学 2区
	药学 1区

最新中科院SCI期刊分区

（2025年3月升级版）

大类学科	小类学科	Top期刊	综述期刊
医学 2区	免疫学 2区	否	否
	肿瘤学 2区
	药学 2区

期刊简介

An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

出版信息
出版商	Springer International Publishing
期刊官网	https://www.springer.com/40259
涉及的研究方向	医学-免疫学
刊期	Bimonthly
年文章数	55
出版国家或地区	NEW ZEALAND
是否OA	否
SCI期刊收录coverage	Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore)

Cite Score相关

Cite Score

（2025年最新版）

Cite Score

SJR

SNIP

排名

10.6

2.29

1.621

学科	分区
大类学科：Medicine 小类学科：Pharmacology (medical)	Q1
大类学科：Medicine 小类学科：Pharmacology	Q1
大类学科：Medicine 小类学科：Biotechnology	Q1